Unbiased Analysis of Today's Healthcare Issues

Part B drug reimbursement

In the past Medicare has reimbursed physicians that administer Part B drugs–typically injectable medications administered in a physician’s office–at 6% of the drug’s cost.  The 6% aims to cover the cost of purchasing and storing the drug as well as administering it.  Because physician reimbursement is proportional to the cost of the drug, physicians have […]

Read the rest of this entry »

Precision acquires ACT Oncology

My employer, the Precision Medicine Group, recently made a new acquisition.  Details are in this press release and the excerpt below. Precision for Medicine, part of the Precision Medicine Group, announced today that it has executed a binding agreement to acquire ACT Oncology, the leading contract research organization (CRO) specializing exclusively in the field of oncology. ACT […]

Read the rest of this entry »

Benefits of mammogram oversold?

That is what one new study finds. The Boston Globe reports that: Doctors may have oversold the benefits of mammography and underplayed its risks, which has left many women unable to make an informed decision about whether or not to have regular breast cancer screenings beginning at age 40. That troubling finding is based on […]

Read the rest of this entry »

Access to Oncology Care

Oftentimes, health services research measure access as the distance between a patient and the nearest provider of a given type (e.g., hospital, physician).  This issue of access is particularly relevant for individuals with cancer, since cancer care typically requires supervisions from specialist oncologists.  In most cases, health services researchers assume that individuals located far from […]

Read the rest of this entry »